Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Janssen Pharmaceuticals"
Count: 2348
Selected: 0
NCT IDTitle
NCT03915886A Study of JNJ-64530440 in Healthy Japanese Male Participants
NCT02342249Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
NCT00207688A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
NCT01026376An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)
NCT05567185A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer
NCT05167825A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension
NCT04868916An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa
NCT04773522A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma
NCT04683029A Study of Guselkumab in Participants With Systemic Sclerosis
NCT04630145A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
NCT04459507A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan
NCT04397263A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT04034095A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
NCT05926583A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
NCT04696809A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
NCT04882072A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
NCT04945733A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer
NCT04325828A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma
NCT05242432A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants
NCT05039710A Study of JNJ-75220795 in Japanese Participants
NCT04062448A Study of Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM)
NCT03242889A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma
NCT03474679A Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD)
NCT04963725A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice
NCT05062200A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants
NCT03547037A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers
NCT03981744A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
NCT05159128A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants
NCT04509947A Study of Ad26.COV2.S in Adults (COVID-19)
NCT04791332A Study of JNJ-67953964 in Healthy Japanese Adult Male Participants
NCT04713930A Study of JNJ-61393215 in Healthy Japanese Male Participants
NCT04677530A Study of JNJ-40411813 in Healthy Japanese Male Participants
NCT04354480A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older
NCT04306302A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese Adults
NCT04500808A Study of Macitentan, in Healthy Japanese Male Participants
NCT02918318A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression
NCT03617016Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia
NCT02325219An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis
NCT02162836A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT02918331A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation
NCT03053024Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants
NCT02365623An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)
NCT02343744An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
NCT02993250A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive
NCT03689153A Study of JNJ-63733657 in Healthy Japanese Participants
NCT03618160A Study to Assess the Safety, Tolerability and Pharmacokinetics of Subcutaneous (SC) Injections of JNJ-64565111 in Healthy Male Japanese Participants and to Assess Pharmacokinetics Following Subcutaneous Injections of JNJ-64565111 in Healthy Male Caucasian Participants
NCT02556892A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT02641730An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis
NCT03196531A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets
NCT02015533A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR8020 in Japanese Healthy Participants